115 related articles for article (PubMed ID: 3780055)
1. Gm allotypes in multiple sclerosis: influence susceptibility in HLA-DQwl-positive patients from the North-East of Scotland.
Francis DA; Brazier DM; Batchelor JR; McDonald WI; Downie AW; Hern JE
Clin Immunol Immunopathol; 1986 Dec; 41(3):409-16. PubMed ID: 3780055
[TBL] [Abstract][Full Text] [Related]
2. Multiple sclerosis in north-east Scotland. An association with HLA-DQw1.
Francis DA; Batchelor JR; McDonald WI; Hing SN; Dodi IA; Fielder AH; Hern JE; Downie AW
Brain; 1987 Feb; 110 ( Pt 1)():181-96. PubMed ID: 3492235
[TBL] [Abstract][Full Text] [Related]
3. Alpha-1-antitrypsin (Pi) types in multiple sclerosis and lack of interaction with immunoglobulin (Gm) markers.
Francis DA; Klouda PT; Brazier DM; Batchelor JR; McDonald WI; Hern JE
J Immunogenet; 1988; 15(5-6):251-5. PubMed ID: 3267150
[TBL] [Abstract][Full Text] [Related]
4. HLA-DR-dependent variation of intrathecal IgG1 (Gm) allotype synthesis in multiple sclerosis.
Salier JP; Martin-Mondiere C; Sesboüé R; Daveau M; Goust JM; Govaerts A; Schuller E; Degos JD
J Immunol; 1985 Mar; 134(3):1551-4. PubMed ID: 3855432
[TBL] [Abstract][Full Text] [Related]
5. Association of CSF IgG concentration and immunoglobulin allotype in multiple sclerosis and optic neuritis.
Sandberg-Wollheim M; Baird LG; Schanfield MS; Knoppers MH; Youker K; Tachovsky TG
Clin Immunol Immunopathol; 1984 May; 31(2):212-21. PubMed ID: 6713741
[TBL] [Abstract][Full Text] [Related]
6. Combined influences of Gm and HLA phenotypes upon multiple sclerosis susceptibility and severity.
Salier JP; Sesboüé R; Martin-Mondière C; Daveau M; Cesaro P; Cavelier B; Coquerel A; Legrand L; Goust JM; Degos JD
J Clin Invest; 1986 Aug; 78(2):533-8. PubMed ID: 3461005
[TBL] [Abstract][Full Text] [Related]
7. HLA and multiple sclerosis in south east Wales.
Swingler RJ; Kirk PF; Darke C; Compston DA
J Neurol Neurosurg Psychiatry; 1987 Sep; 50(9):1153-5. PubMed ID: 3499485
[TBL] [Abstract][Full Text] [Related]
8. A linkage analysis of the Gm locus and multiple sclerosis.
Haile RW; Goldstein A; Field L; Marazita ML
Genet Epidemiol; 1985; 2(1):29-34. PubMed ID: 3876966
[TBL] [Abstract][Full Text] [Related]
9. Immunoglobulin allotypes and susceptibility to multiple sclerosis. An epidemiological and genetic study in the Hautes-Pyrénées county of France.
Blanc M; Clanet M; Berr C; Dugoujon JM; Ruydavet B; Ducos SJ; Rascol A; Alpérovitch A
J Neurol Sci; 1986 Aug; 75(1):1-5. PubMed ID: 3091773
[TBL] [Abstract][Full Text] [Related]
10. HLA genetic determinants in familial MS. A study from the Grampian region of Scotland.
Francis DA; Batchelor JR; McDonald WI; Dodi IA; Hing SN; Hern JE; Downie AW
Tissue Antigens; 1987 Jan; 29(1):7-12. PubMed ID: 3590146
[TBL] [Abstract][Full Text] [Related]
11. Susceptibility to human cutaneous leishmaniasis and HLA, Gm, Km markers.
Barbier D; Demenais F; Lefait JF; David B; Blanc M; Hors J; Feingold N
Tissue Antigens; 1987 Aug; 30(2):63-7. PubMed ID: 3478848
[TBL] [Abstract][Full Text] [Related]
12. Immunoglobulin G heavy chain (Gm) allotypes in multiple sclerosis.
Pandey JP; Goust JM; Salier JP; Fudenberg HH
J Clin Invest; 1981 Jun; 67(6):1797-1800. PubMed ID: 6787085
[TBL] [Abstract][Full Text] [Related]
13. IgG (Gm) allotypes and multiple sclerosis in a French population: phenotype distribution and quantitative abnormalities in CSF with respect to sex, disease severity, and presence of intrathecal antibodies.
Sesboüé R; Daveau M; Degos JD; Martin-Mondiere C; Goust JM; Schuller E; Rivat-Peran L; Coquerel A; Dujardin M; Salier JP
Clin Immunol Immunopathol; 1985 Nov; 37(2):143-53. PubMed ID: 4042430
[TBL] [Abstract][Full Text] [Related]
14. Susceptibility to multiple sclerosis associated with an immunoglobulin gamma 3 restriction fragment length polymorphism.
Gaiser CN; Johnson MJ; de Lange G; Rassenti L; Cavalli-Sforza LL; Steinman L
J Clin Invest; 1987 Jan; 79(1):309-13. PubMed ID: 2878940
[TBL] [Abstract][Full Text] [Related]
15. HLA and non-HLA phenotyping and genotyping in Austral and Gambier Polynesian Archipelagos.
Dehay C; Gentile B; Jeannet M; Thorsby E; Marcelli-Barge A; Dausset J
Tissue Antigens; 1987 Aug; 30(2):49-62. PubMed ID: 3478847
[TBL] [Abstract][Full Text] [Related]
16. Evidence for the genetic role of human leukocyte antigens in low frequency DRB1*1501 multiple sclerosis patients in Israel.
Karni A; Kohn Y; Safirman C; Abramsky O; Barcellos L; Oksenberg JR; Kahana E; Karussis D; Chapman J; Brautbar C
Mult Scler; 1999 Dec; 5(6):410-5. PubMed ID: 10618697
[TBL] [Abstract][Full Text] [Related]
17. Genetics of multiple sclerosis.
Dyment DA; Sadovnick AD; Ebers GC
Hum Mol Genet; 1997; 6(10):1693-8. PubMed ID: 9300661
[TBL] [Abstract][Full Text] [Related]
18. Shared HLA class II-associated genetic susceptibility and resistance, related to the HLA-DQB1 gene, in IgA deficiency and common variable immunodeficiency.
Olerup O; Smith CI; Björkander J; Hammarström L
Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10653-7. PubMed ID: 1438261
[TBL] [Abstract][Full Text] [Related]
19. IgG heavy-chain (Gm) allotypes and HLA-antigens in insulin-dependent diabetes mellitus in Korea.
Okimoto K; Nakao Y; Matsumoto H; Min HK; Kim EJ; Lee TH; Yoon JS; Higa S; Oura T; Mimura G
Tohoku J Exp Med; 1983 Dec; 141 Suppl():283-7. PubMed ID: 6440310
[TBL] [Abstract][Full Text] [Related]
20. Immunoglobulin gamma constant gene region polymorphisms in multiple sclerosis.
Hillert J
J Neuroimmunol; 1993 Mar; 43(1-2):9-14. PubMed ID: 8096224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
